BIO vs CERT · rev $2.58B vs rev $385.1M
BIO (BIO) versus Certara Inc (CERT) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Certara Inc (CERT) is a health information services company listed on US.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
Latest reported CERT revenue for 2024-12-31 was $385.1M. Net income was -$12.1M. Revenue was up 8.7% from 2023-12-31 to 2024-12-31. CERT currently screens at market cap $1.86B.
BIO currently screens at market cap $0. CERT currently screens at market cap $1.86B.
Not investment advice. Open the BIO and CERT stock pages for the full models.
Not investment advice.